This book is the second in a series presenting articles that received the most citations in recent years in nanomedicine. The series is edited by a prominent nanotechnology researcher and editor-in-chief of Precision Nanomedicine. The theme of the second volume is about nano-enabled medical applications.
This book is the second in a series presenting articles that received the most citations in recent years in nanomedicine. The series is edited by a prominent nanotechnology researcher and editor-in-chief of Precision Nanomedicine. The theme of the second volume is about nano-enabled medical applications.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Dr. Lajos (Lou) P. Balogh, Ph.D. is the editor-in-chief of Precision Nanomedicine, the official journal of the European Society for Nanomedicine (CLINAM).
Inhaltsangabe
Intelligent nanomaterials for medicine: Carrier platforms and targeting strategies: State of the Art. Nanocarriers as an Emerging Platform for Cancer Therapy. Microfluidic Technologies for Accelerating the Clinical Translation of Nanoparticles. Theranostic Nanomedicine. The Emerging Field of RNA Nanotechnology. Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress. Biomolecular coronas provide the biological identity of nanosized materials. Protein-Nanoparticle Interactions. Rapid Formation of Plasma Protein Corona Critically Affects Nanoparticle Pathophysiology. Normalization of Tumour Blood Vessels Improves the Delivery of Nanomedicines in a Size-Dependent Manner. The Properties and Applications of Nanodiamonds. Nanotechnological Strategies for Engineering Complex Tissues. Promises, Facts and Challenges for Carbon Nanotubes in Imaging and Therapeutics. In vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice. A Pilot Study in Non-Human Primates Shows No Adverse Response to Intravenous Injection of Quantum Dots. Nanomedicines for ocular NSAIDs: State-of-Art Update of the Safety on Drug Delivery. Rare Earth Nanoparticles Prevent Retinal Degeneration Induced by Intracellular Peroxides. Nanomechanical Analysis of Cells from Cancer Patients. Multi-Electrode Array Technologies for Neuroscience and Cardiology.
Intelligent nanomaterials for medicine: Carrier platforms and targeting strategies: State of the Art. Nanocarriers as an Emerging Platform for Cancer Therapy. Microfluidic Technologies for Accelerating the Clinical Translation of Nanoparticles. Theranostic Nanomedicine. The Emerging Field of RNA Nanotechnology. Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress. Biomolecular coronas provide the biological identity of nanosized materials. Protein-Nanoparticle Interactions. Rapid Formation of Plasma Protein Corona Critically Affects Nanoparticle Pathophysiology. Normalization of Tumour Blood Vessels Improves the Delivery of Nanomedicines in a Size-Dependent Manner. The Properties and Applications of Nanodiamonds. Nanotechnological Strategies for Engineering Complex Tissues. Promises, Facts and Challenges for Carbon Nanotubes in Imaging and Therapeutics. In vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice. A Pilot Study in Non-Human Primates Shows No Adverse Response to Intravenous Injection of Quantum Dots. Nanomedicines for ocular NSAIDs: State-of-Art Update of the Safety on Drug Delivery. Rare Earth Nanoparticles Prevent Retinal Degeneration Induced by Intracellular Peroxides. Nanomechanical Analysis of Cells from Cancer Patients. Multi-Electrode Array Technologies for Neuroscience and Cardiology.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
